Company news

Ocumetics Technology Corp news in 2026

Ocumetics Technology Corp's news releases, calls and decks from 2026, newest first.

View company

Ocumetics Announces Changes to Board of Directors; Appoints Sandi Gilbert as Director and Dean Burns as Chairman

October 28, 2026

Ocumetics Provides Summary of Group One Patient Clinical Progress

September 17, 2026

Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries

September 8, 2026

Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries

August 31, 2026

Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement

August 24, 2026

Ocumetics Announces Completion of Second Tranche of Unit Private Placement

July 31, 2026

Ocumetics Announces Upsizing of Unit Private Placement

July 30, 2026

Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study

July 9, 2026

Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones

June 2, 2026

Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens

May 12, 2026

Ocumetics Announces Offering of Units

April 29, 2026

Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life

April 20, 2026

Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change

April 14, 2026

Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

April 1, 2026

Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design

March 31, 2026

Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy

February 26, 2026

Ocumetics Announces Appointment of Raymond Marks to Board of Directors

February 24, 2026

Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update

February 10, 2026

Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

February 3, 2026

Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures

January 30, 2026

Ocumetics Announces Transition of Chief Medical Officer Consulting Role

January 9, 2026

Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

January 2, 2026

Decks in 2026